DavidCunninghamDavid M. Cunningham14852Cunningham, DavidM.Postdoc Fellows and Associatesprns:coAuthorOfcoauthor ofFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:similarTosimilar toprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierAddressvivo:authorInAuthorshipselected publicationsvivo:authorRankauthor rank in publicationAuthorshipDepartmentDivisionvivo:hasResearchArearesearch areasvivo:hrJobTitleHR job titleInformation Resourcevivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcevivo:mailingAddressmailing addressvivo:middleNamemiddle name or initialvivo:personInPositionpositionsPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonGenitourinary Medical OncologyGI Medical OncologyGynecological Oncology & Reproductive MedicineMolecular & Cellular OncologyMD AndersonMIEN-CHIEHUNGMIEN-CHIE HUNG8427HUNG, MIEN-CHIEProfessorJAFFER AAJANIJAFFER A AJANI8473AJANI, JAFFER AProfessorCHRISTOPHER JLOGOTHETISCHRISTOPHER J LOGOTHETIS8480LOGOTHETIS, CHRISTOPHER JProfessorANIL KSOODANIL K SOOD9048SOOD, ANIL KProfessor74Professor21Chair14Associate ProfessorD011471Disorders75057370.293776Prostatic NeoplasmsD050256Chemicals & Drugs880.989311Antimitotic AgentsD009842Chemicals & Drugs2414290.815309OligopeptidesD001859Disorders67825640.39737Bone NeoplasmsD049109Physiology146972160.393248Cell ProliferationDepartment of MedicineDepartment of PediatricsMedicine-Gastroenterology & HepatolBaylor College of MedicineANDRASHECZEYANDRAS HECZEY0.000000000000000.000000000000004430HECZEY, ANDRASAssociate ProfessorHASHEMEL-SERAGHASHEM EL-SERAG29.70560750000000-95.3846773000000068EL-SERAG, HASHEMProfessortrue1ProfessorProfessortrue1Postdoc Fellows and AssociatesPostdoc Fellows and Associates0.5776690.0023440956research areas0.2453940.05743862coauthor of5.956311.137360similar to117selected publicationsAuthorship 959758428240383Zhang Q, Liu S, Ge D, Cunningham DM, Huang F, Ma L, Burris TP, You ZThe ProstateTargeting Th17-IL-17 Pathway in Prevention of Micro-Invasive Prostate Cancer in a Mouse Model. Prostate. 2017 Jun; 77(8):888-899.Prostate2017-02-27T00:00:002017Targeting Th17-IL-17 Pathway in Prevention of Micro-Invasive Prostate Cancer in a Mouse Model.71Postdoc Fellows and AssociatesPostDocAuthorship 9900531Authorship 9900541Authorship 9900551Authorship 990056530038943Cunningham D, Zhang Q, Liu S, Parajuli KR, Nie Q, Ma L, Zhang A, Chen Z, You ZAmerican journal of clinical and experimental urologyInterleukin-17 promotes metastasis in an immunocompetent orthotopic mouse model of prostate cancer. Am J Clin Exp Urol. 2018; 6(3):114-122.Am J Clin Exp Urol2018-06-15T00:00:002018Interleukin-17 promotes metastasis in an immunocompetent orthotopic mouse model of prostate cancer.27325602Cunningham D, Parajuli KR, Zhang C, Wang G, Mei J, Zhang Q, Liu S, You ZThe ProstateMonomethyl Auristatin E Phosphate Inhibits Human Prostate Cancer Growth. Prostate. 2016 11; 76(15):1420-30.Prostate2016-06-21T00:00:002016Monomethyl Auristatin E Phosphate Inhibits Human Prostate Cancer Growth.26146646Cunningham D, You ZJournal of biological methodsIn vitro and in vivo model systems used in prostate cancer research. J Biol Methods. 2015; 2(1).J Biol Methods2015-01-01T00:00:002015In vitro and in vivo model systems used in prostate cancer research.18446091Schnatz PF, Romegialli A, Abrantes J, Marakovits K, Cunningham D, O'Sullivan DM, North American Menopause SocietyMenopause (New York, N.Y.)The North American Menopause Society: from abstract to publication. Menopause. 2008 Sep-Oct; 15(5):996-1001.Menopause2008-09-01T00:00:002008The North American Menopause Society: from abstract to publication.true1Associate ProfessorAssociate ProfessorPediatricts-Oncology AICTAuthorship 1057159236609146Patra T, Cunningham DM, Meyer K, Toth K, Ray RB, Heczey A, Ray RMolecular therapy : the journal of the American Society of Gene TherapyTargeting Lin28 axis enhances glypican-3-CAR T?cell efficacy against hepatic tumor initiating cell population. Mol Ther. 2023 03 01; 31(3):715-728.Mol Ther2023-01-06T00:00:002023Targeting Lin28 axis enhances glypican-3-CAR T?cell efficacy against hepatic tumor initiating cell population.Authorship 1085244338118368Ajani J, El Hajbi F, Cunningham D, Alsina M, Thuss-Patience P, Scagliotti GV, Van den Eynde M, Kim SB, Kato K, Shen L, Li L, Ding N, Shi J, Barnes G, Van Cutsem EESMO openTislelizumab versus chemotherapy as second-line treatment for European and North American patients with advanced or metastatic esophageal squamous cell carcinoma: a subgroup analysis of the randomized phase III RATIONALE-302 study. ESMO Open. 2024 Jan; 9(1):102202.ESMO Open2023-12-19T00:00:002023Tislelizumab versus chemotherapy as second-line treatment for European and North American patients with advanced or metastatic esophageal squamous cell carcinoma: a subgroup analysis of the randomized phase III RATIONALE-302 study.true1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessor